Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. It is preventable and curable. Malaria vaccines are used to prevent the spread of malaria. The only approved vaccine, as of 2021, is RTS,S, known by the brand name Mosquirix. In October 2021, the World Health Organization (WHO) for the first time recommended the large-scale use of a malaria vaccine for children living in areas with moderate-to-high malaria transmission. Four injections of malaria vaccines are required for full protection.
Market Dynamics
Key players operating in the global malaria vaccine market are focusing on adoption of growth strategies such as agreements which are expected to drive market growth during the forecast period. For instance, in January 2021, GlaxoSmithKline (GSK), a science-led global healthcare company, PATH (Program for Appropriate Technology in Health), nonprofit global health organization based in Seattle, U.S., and Bharat Biotech (BBIL), is an Indian multinational biotechnology company announced the signing of a product transfer agreement for the malaria vaccine, RTS,S/AS01E. The agreement includes, transfer of manufacturing of the RTS,S antigen part of the vaccine and the grant of a license on all rights pertaining to the RTS,S/AS01 malaria vaccine to BBIL. GSK will retain the production of the adjuvant of the vaccine (AS01E) and will supply it to BBIL. Moreover, increasing research and development for malaria vaccine is expected to propel the global malaria vaccine market over the forecast period. For instance, in April 2021, scientists at the University of Oxford’s Jenner Institute announced that their Phase IIb trial of a candidate malaria vaccine achieved 77% efficacy in early stage trials – making it the first malaria vaccine to meet the WHO’s target of 75%. The Phase IIb trial of the vaccine candidate, R21, enrolled 450 children in Burkina Faso, one of the 10 countries with the highest cases of malaria and subsequent deaths.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 28 market data tables and 32 figures on "Global Malaria Vaccines Market” - Forecast to 2030
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients